{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:01:47Z","timestamp":1792033307252,"version":"4.4.0"},"reference-count":49,"publisher":"WHO Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. World Health Organ."],"published-print":{"date-parts":[[2017,3,1]]},"DOI":"10.2471\/blt.16.173039","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T14:42:18Z","timestamp":1487860938000},"page":"210-219C","source":"Crossref","is-referenced-by-count":107,"title":["Pre-exposure rabies prophylaxis: a systematic review"],"prefix":"10.2471","volume":"95","author":[{"given":"Jocelyn A","family":"Kessels","sequence":"first","affiliation":[{"name":"School of Veterinary Science, University of Queensland Gatton Campus, Via Warrego Highway, Gatton, Queensland 4343, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Recuenco","sequence":"additional","affiliation":[{"name":"National Centre for Public Health, Instituto Nacional de Salud, Lima, Peru."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Navarro-Vela","sequence":"additional","affiliation":[{"name":"Directorate General of Strategic Interventions in Public Health, Ministry of Health, Lima, Peru."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffy","family":"Deray","sequence":"additional","affiliation":[{"name":"Diseases Prevention and Control Bureau, Department of Health, Manilla, Philippines."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vigilato","sequence":"additional","affiliation":[{"name":"Veterinary Public Health Unit, Pan American Health Organisation\u2013World Health Organisation, Rio de Janeiro, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegund","family":"Ertl","sequence":"additional","affiliation":[{"name":"Wistar Institute Vaccine Center, Philadelphia, United States of America (USA)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durrheim","sequence":"additional","affiliation":[{"name":"Hunter Medical Research Institution, University of Newcastle, Newcastle, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Rees","sequence":"additional","affiliation":[{"name":"Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H","family":"Nel","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Abela-Ridder","sequence":"additional","affiliation":[{"name":"Neglected Zoonotic Diseases, World Health Organization, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Briggs","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Kansas State University, Manhattan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1305","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"issue":"4","key":"key-10.2471\/BLT.16.173039-201702231541-R1","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies.","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"key-10.2471\/BLT.16.173039-201702231541-R2","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia.","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"key-10.2471\/BLT.16.173039-201702231541-R3","doi-asserted-by":"crossref","first-page":"g7827","DOI":"10.1136\/bmj.g7827","article-title":"The prevention and management of rabies.","volume":"350","author":"Crowcroft","year":"2015;","journal-title":"BMJ"},{"issue":"18","key":"key-10.2471\/BLT.16.173039-201702231541-R4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.vaccine.2013.12.031","article-title":"Rabies: underused vaccines, unnecessary deaths.","volume":"32","author":"Dodet","year":"2014","journal-title":"Vaccine"},{"issue":"32","key":"key-10.2471\/BLT.16.173039-201702231541-R5","first-page":"309","article-title":"Rabies vaccines: WHO position paper","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.2471\/BLT.16.173039-201702231541-R6","doi-asserted-by":"publisher","year":"2014","journal-title":"Estrategia nacional de zoonosis-MINSA. Informe 37-2015. Resultados plan de vacunaci\u00f3n antirr\u00e1bica de pre-exposici\u00f3n en comunidades en riesgo de rabia de la Region Amazonas: Per\u00fa 2011\u20132014.","DOI":"10.1016\/j.vaccine.2010.02.093"},{"issue":"19","key":"key-10.2471\/BLT.16.173039-201702231541-R7","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/j.vaccine.2010.02.093","article-title":"Report of the sixth AREB meeting, Manila, The Philippines, 10\u201312 November 2009.","volume":"28","author":"Dodet","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"key-10.2471\/BLT.16.173039-201702231541-R8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"key-10.2471\/BLT.16.173039-201702231541-R9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4269\/ajtmh.2012.11-0689","article-title":"Evidence of rabies virus exposure among humans in the Peruvian Amazon.","volume":"87","author":"Gilbert","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"key-10.2471\/BLT.16.173039-201702231541-R10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1590\/S0102-311X2001000600038","article-title":"Common vampire bat attacks on humans in a village of the Amazon region of Brazil.","volume":"17","author":"Schneider","year":"2001","journal-title":"Cad Saude Publica"},{"issue":"1742","key":"key-10.2471\/BLT.16.173039-201702231541-R11","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1098\/rspb.2012.0538","article-title":"Ecological and anthropogenic drivers of rabies exposure in vampire bats: implications for transmission and control.","volume":"279","author":"Streicker","year":"2012","journal-title":"Proc Biol Sci"},{"key":"key-10.2471\/BLT.16.173039-201702231541-R12","unstructured":"National rabies prevention and control program. Manual of operations (2012). Manila: Department of Health, Philippines; 2012. Available from: http:\/\/www.doh.gov.ph\/sites\/default\/files\/publications\/FINALMOP6.4.13WORDRADMay30.pdf [cited 2016 Nov 18]."},{"issue":"3","key":"key-10.2471\/BLT.16.173039-201702231541-R13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/zph.12060","article-title":"Fighting rabies in Eastern Europe, the Middle East and Central Asia\u2013experts call for a regional initiative for rabies elimination.","volume":"61","author":"Aikimbayev","year":"2014","journal-title":"Zoonoses Public Health"},{"issue":"8","key":"key-10.2471\/BLT.16.173039-201702231541-R14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.vaccine.2013.12.019","article-title":"Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students.","volume":"32","author":"Banga","year":"2014","journal-title":"Vaccine"},{"key":"key-10.2471\/BLT.16.173039-201702231541-R15","doi-asserted-by":"publisher","first-page":"601789","DOI":"10.4061\/2011\/601789","article-title":"Using intradermal rabies vaccine to boost immunity in people with low rabies antibody levels.","volume":"2011","author":"Brown","year":"2011","journal-title":"Adv Prev Med"},{"issue":"31","key":"key-10.2471\/BLT.16.173039-201702231541-R16","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1016\/j.vaccine.2008.04.081","article-title":"Intradermal pre-exposure rabies vaccine elicits long lasting immunity.","volume":"26","author":"Brown","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"key-10.2471\/BLT.16.173039-201702231541-R17","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children.","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"key-10.2471\/BLT.16.173039-201702231541-R18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1590\/S0034-89102010005000005","article-title":"Equivalence between pre-exposure schemes for human rabies and evaluation of the need for serological monitoring.","volume":"44","author":"Cunha","year":"2010","journal-title":"Rev Saude Publica"},{"issue":"18","key":"key-10.2471\/BLT.16.173039-201702231541-R19","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.vaccine.2009.02.012","article-title":"Report of the Fifth AREB Meeting Ho Chi Minh City, Vietnam, 17\u201320 November 2008.","volume":"27","author":"Dodet","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"key-10.2471\/BLT.16.173039-201702231541-R20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.tmaid.2015.05.008","article-title":"Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.","volume":"13","author":"Jelinek","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"key-10.2471\/BLT.16.173039-201702231541-R21","doi-asserted-by":"publisher","first-page":"403201","DOI":"10.4061\/2011\/403201","article-title":"Immunogenicity of simulated PCECV postexposure booster doses 1, 3, and 5 years after 2-dose and 3-dose primary rabies vaccination in schoolchildren.","volume":"2011","author":"Kamoltham","year":"2011","journal-title":"Adv Prev Med"},{"issue":"2","key":"key-10.2471\/BLT.16.173039-201702231541-R22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"key":"key-10.2471\/BLT.16.173039-201702231541-R23","first-page":"393","article-title":"One or three intradermal injections within one week for rabies pre-exposure immunization.","volume":"131","author":"Khawplod","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"19","key":"key-10.2471\/BLT.16.173039-201702231541-R24","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.vaccine.2011.12.028","article-title":"One clinic visit for pre-exposure rabies vaccination (a preliminary one year study).","volume":"30","author":"Khawplod","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"key-10.2471\/BLT.16.173039-201702231541-R25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1708-8305.2007.00120.x","article-title":"Immunogenicity study of abbreviated rabies preexposure vaccination schedules.","volume":"14","author":"Khawplod","year":"2007","journal-title":"J Travel Med"},{"issue":"9066","key":"key-10.2471\/BLT.16.173039-201702231541-R26","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(96)10085-4","article-title":"Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.","volume":"349","author":"Lang","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"key-10.2471\/BLT.16.173039-201702231541-R27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/tropej\/fmm100","article-title":"Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.","volume":"55","author":"Lang","year":"2009","journal-title":"J Trop Pediatr"},{"issue":"6","key":"key-10.2471\/BLT.16.173039-201702231541-R28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tmaid.2013.09.006","article-title":"Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.","volume":"11","author":"Lau","year":"2013","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"key-10.2471\/BLT.16.173039-201702231541-R29","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.ijid.2009.08.008","article-title":"Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.","volume":"14","author":"Lim","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"8","key":"key-10.2471\/BLT.16.173039-201702231541-R30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1517\/14712598.2012.691162","article-title":"Preventative childhood vaccination to rabies.","volume":"12","author":"Liu","year":"2012","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"key-10.2471\/BLT.16.173039-201702231541-R31","first-page":"99","article-title":"Pre-exposure vaccination with purified chick embryo cell rabies vaccines in children.","volume":"7","author":"Lumbiganon","year":"1989","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"7","key":"key-10.2471\/BLT.16.173039-201702231541-R32","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.4161\/hv.24502","article-title":"Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).","volume":"9","author":"Malerczyk","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"key-10.2471\/BLT.16.173039-201702231541-R33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule\u2013a case series of 420 travelers.","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"issue":"4","key":"key-10.2471\/BLT.16.173039-201702231541-R34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"key-10.2471\/BLT.16.173039-201702231541-R35","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.4161\/hv.25203","article-title":"Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route.","volume":"9","author":"Ravish","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"key-10.2471\/BLT.16.173039-201702231541-R36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4161\/hv.4.5.5987","article-title":"Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).","volume":"4","author":"Shanbag","year":"2008","journal-title":"Hum Vaccin"},{"issue":"11","key":"key-10.2471\/BLT.16.173039-201702231541-R37","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.trstmh.2009.03.007","article-title":"Immunogenicity and booster efficacy of pre-exposure rabies vaccination.","volume":"103","author":"Strady","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"key-10.2471\/BLT.16.173039-201702231541-R38","first-page":"589","article-title":"Time interval for booster vaccination following re-exposure to rabies in previously vaccinated subjects.","volume":"5","author":"Sudarshan","year":"2011","journal-title":"Asian Biomed"},{"issue":"10","key":"key-10.2471\/BLT.16.173039-201702231541-R39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s13312-014-0504-y","article-title":"Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years\u2013India, 2014 and updates on immunization.","volume":"51","author":"Vashishtha","year":"2014","journal-title":"Indian Pediatr"},{"issue":"3","key":"key-10.2471\/BLT.16.173039-201702231541-R40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"13","key":"key-10.2471\/BLT.16.173039-201702231541-R41","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.vaccine.2013.01.035","article-title":"Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.","volume":"31","author":"Wongsaroj","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"key-10.2471\/BLT.16.173039-201702231541-R42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0264-410X(91)90221-Q","article-title":"Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?","volume":"9","author":"Bernard","year":"1991","journal-title":"Vaccine"},{"issue":"11-12","key":"key-10.2471\/BLT.16.173039-201702231541-R43","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/S0264-410X(00)00368-6","article-title":"Pre-exposure rabies vaccination: strategies and cost-minimization study.","volume":"19","author":"Strady","year":"2001","journal-title":"Vaccine"},{"issue":"42","key":"key-10.2471\/BLT.16.173039-201702231541-R44","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1016\/j.vaccine.2013.07.034","article-title":"Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX\u2122 adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.","volume":"31","author":"DiStefano","year":"2013","journal-title":"Vaccine"},{"issue":"12","key":"key-10.2471\/BLT.16.173039-201702231541-R45","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.imbio.2013.05.006","article-title":"Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB\/c mice.","volume":"218","author":"Hu","year":"2013","journal-title":"Immunobiology"},{"issue":"8","key":"key-10.2471\/BLT.16.173039-201702231541-R46","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.","volume":"200","author":"Cenna","year":"2009","journal-title":"J Infect Dis"},{"issue":"10","key":"key-10.2471\/BLT.16.173039-201702231541-R47","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.","volume":"12","author":"Xiang","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"key-10.2471\/BLT.16.173039-201702231541-R48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"key-10.2471\/BLT.16.173039-201702231541-R49","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1128\/JVI.02924-14","article-title":"Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.","volume":"89","author":"Rennick","year":"2015","journal-title":"J Virol"}],"container-title":["Bulletin of the World Health Organization"],"original-title":[],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:18:07Z","timestamp":1742404687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5328107\/pdf\/BLT.16.173039.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,11,25]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.2471\/blt.16.173039","relation":{},"ISSN":["0042-9686"],"issn-type":[{"value":"0042-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}